^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

quinacrine (CBL0102)

i
News
Trials
Company:
Incuron
Drug class:
mTOR inhibitor, PI3K inhibitor, AKT inhibitor, NF-κB inhibitor, Heat shock factor 1 inhibitor
Related drugs:
News
Trials